Five-lipoxygenase-activating protein-mediated cyld attenuation is a candidate driver in hepatic malignant lesion

HIGHLIGHTS

• who: Kun-kai Su from the Qilu Hospital of Shandong University, China have published the research: Five-lipoxygenase-activating protein-mediated CYLD attenuation is a candidate driver in hepatic malignant lesion, in the Journal: (JOURNAL)
• what: The authors report that FLAP highly expresses in the resection tissues from HCC patients. This study reveals that both the 5LO/LTB4 bypass and the COX/PGE2 pathway in AAI-treated livers of canines do not change in expression, indicating that both pathways contribute less to the generation of lipid proinflammatory mediators . Based on the knowledge , the authors report . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.